Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on pricing and tariffs.
Trending
- ‘Several hurricanes have come close’: I’m 73 and live in a mobile home in Florida. Do I ditch my $2,400 home insurance?
- Trump says military is building underground complex at White House
- Tehran briefly loses power after strikes as peace push ramps up
- Trump says he has ‘no problem’ with Russian oil tanker bringing relief to Cuba despite blockade
- Video Sky turns red in Western Australia ahead of tropical cyclone
- Elite 8 winners, losers: UConn comeback, droughts end, Duke chokes again
- Trump warns US could ‘take the oil in Iran’ as Mideast war escalates
- The Iran war; high gas prices; Trump’s approval ratings : NPR
Monday, March 30
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
